InsightfulValue
← Home

Bio-Techne
Bio-Techne

-4.09%

Healthcare & biotech / Biotechnology and Life Sciences Solutions


πŸ”§ Tools

βœ… Due Diligence
Company at a Glance

More reviews (1)
Bio-Techne

πŸ“Š Get full analytics about Bio-Techne

Sign up for free or log in

πŸš€ Don’t miss "The Checklist Value Investor β€” A Smarter Way to Pick Stocks" β€” free!

Price
Live  
Infographic
Infographics
Overview
Bio-Techne is a global life sciences company that provides innovative research tools and solutions to scientists and clinicians. The company was established in 1976 and is headquartered in Minneapolis, Minnesota. It operates through four key divisions: Bio-Techne, R&D Systems, Novus Biologicals, and ProteinSimple.
Bio-Techne's products include proteins, antibodies, assays, and reagents for a wide range of research areas such as cell biology, immunology, neuroscience, and drug discovery. The company also offers services such as protein analysis, contract manufacturing, and custom antibody development.
Bio-Techne has a strong global presence, with offices and distribution centers in North America, Europe, and Asia-Pacific. It serves customers in over 160 countries and has collaborations with leading pharmaceutical and biotech companies.
The company is committed to advancing science and improving human health through its products and services. It invests heavily in research and development to continuously innovate and expand its product portfolio. Bio-Techne also supports the scientific community through educational initiatives and partnerships with academic institutions.
In addition to its research tools and solutions, Bio-Techne has a strong focus on corporate social responsibility and sustainability. It has implemented various initiatives to reduce its environmental impact and support the communities where it operates.
Overall, Bio-Techne is a leading company in the life sciences industry, known for its high-quality products, scientific expertise, and commitment to improving human health.
How to explain to a 10 year old kid about the company?
Bio-Techne

πŸ“ˆ Want to read more about Bio-Techne?

Sign up for free or log in

πŸ“– Get insights from "The Checklist Value Investor β€” A Smarter Way to Pick Stocks" now!

QmlvLVRlY2 huZSBpcyBh IGNvbXBhbn kgdGhhdCBt YWtlcyBzcG VjaWFsIHRv b2xzIGFuZC Bwcm9kdWN0 cyBmb3Igc2 NpZW50aXN0 cyBhbmQgcm VzZWFyY2hl cnMgd2hvIH N0dWR5IGxp dmluZyB0aG luZ3MsIGxp a2UgY2VsbH MgYW5kIHBy b3RlaW5zLi BUaGluayBv ZiB0aGVtIG xpa2UgYSBi aWcgdG9vbG JveCBmdWxs IG9mIGdhZG dldHMgdGhh dCBoZWxwIH NjaWVudGlz dHMgbGVhcm 4gbW9yZSBh Ym91dCBkaX NlYXNlcywg aG93IG91ci Bib2RpZXMg d29yaywgYW 5kIGV2ZW4g aG93IHRvIG NyZWF0ZSBu ZXcgbWVkaW NpbmVzLjxi cj5UaGUgd2 F5IEJpby1U ZWNobmUgbW FrZXMgbW9u ZXkgaXMgYn kgc2VsbGlu ZyB0aGVzZS Bwcm9kdWN0 cyB0byB1bm l2ZXJzaXRp ZXMsIGhvc3 BpdGFscywg YW5kIGNvbX BhbmllcyB0 aGF0IGRvIH Jlc2VhcmNo LiBUaGV5IG hhdmUgdGhp bmdzIGxpa2 UgcHJvdGVp bnMsIGFudG lib2RpZXMg KHdoaWNoIG hlbHAgc2Np ZW50aXN0cy BmaW5kIGFu ZCBzdHVkeS BvdGhlciBw cm90ZWlucy ksIGFuZCBt YWNoaW5lcy B0aGF0IGhl bHAgbWVhc3 VyZSBhbmQg YW5hbHl6ZS BkaWZmZXJl bnQgYmlvbG 9naWNhbCBz YW1wbGVzLi BXaGVuZXZl ciByZXNlYX JjaGVycyBu ZWVkIHRoZX NlIHRvb2xz LCB0aGV5IG J1eSB0aGVt IGZyb20gQm lvLVRlY2hu ZS48YnI+Qm lvLVRlY2hu ZSBpcyBzdW NjZXNzZnVs IGJlY2F1c2 UgdGhleSBt YWtlIGhpZ2 gtcXVhbGl0 eSBwcm9kdW N0cyB0aGF0 IHNjaWVudG lzdHMgdHJ1 c3QuIElmIH NjaWVudGlz dHMgY2FuIH JlbHkgb24g dGhlaXIgdG 9vbHMsIHRo ZXnigJlsbC BrZWVwIGNv bWluZyBiYW NrIHRvIGJ1 eSBtb3JlLC BhbmQgdGhh dCBoZWxwcy B0aGUgY29t cGFueSBlYX JuIG1vbmV5 LiBUaGV5IG FyZSBhbHNv IGFsd2F5cy Bsb29raW5n IGZvciBuZX cgYW5kIGJl dHRlciB3YX lzIHRvIGhl bHAgcmVzZW FyY2hlcnMs IHdoaWNoIG tlZXBzIHRo ZW0gYWhlYW Qgb2YgdGhl IGNvbXBldG l0aW9uLiA8 YnI+SW4gdG hlIGZ1dHVy ZSwgQmlvLV RlY2huZSBp cyBsaWtlbH kgdG8gc3Rh eSBzdWNjZX NzZnVsIGJl Y2F1c2Ugc2 NpZW5jZSBh bmQgcmVzZW FyY2ggYXJl IGFsd2F5cy BhZHZhbmNp bmcuIFRoZX JlIHdpbGwg YWx3YXlzIG JlIG5ldyBk aXNjb3Zlcm llcyB0byBt YWtlIGFuZC BkaXNlYXNl cyB0byBzdH VkeSwgd2hp Y2ggbWVhbn MgYSBjb250 aW51ZWQgbm VlZCBmb3Ig dGhlaXIgcH JvZHVjdHMu IFBsdXMsIG FzIHRlY2hu b2xvZ3kgZ2 V0cyBiZXR0 ZXIsIHRoZX kgY2FuIGNy ZWF0ZSBldm VuIG1vcmUg aW5ub3ZhdG l2ZSB0b29s cyB0aGF0IH dpbGwgaGVs cCBzY2llbn Rpc3RzIHdv cmsgbW9yZS BlZmZpY2ll bnRseSwgbG VhZGluZyB0 byBtb3JlIH NhbGVzIGFu ZCBncm93dG guIFNvLCBh cyBsb25nIG FzIHRoZXJl IGlzIGN1cm lvc2l0eSBh Ym91dCBsaW ZlIGFuZCBo b3cgaXQgd2 9ya3MsIEJp by1UZWNobm Ugd2lsbCBi ZSB0aGVyZS wgaGVscGlu ZyBzY2llbn Rpc3RzIGFs b25nIHRoZS B3YXkhPGJy Pg==
What is special about the company?
Bio-Techne

πŸ“ˆ Want to read more about Bio-Techne?

Sign up for free or log in

πŸ“š Your free copy of "The Checklist Value Investor β€” A Smarter Way to Pick Stocks" is waiting

MS4gUmVub3 duZWQgQmlv dGVjaCBDb2 1wYW55OiBC aW8tVGVjaG 5lIGlzIGEg Z2xvYmFsbH kgcmVjb2du aXplZCBiaW 90ZWNoIGNv bXBhbnkgdG hhdCBzcGVj aWFsaXplcy BpbiBwcm92 aWRpbmcgaW 5ub3ZhdGl2 ZSBzb2x1dG lvbnMgZm9y IGxpZmUgc2 NpZW5jZSBy ZXNlYXJjaC wgZGlhZ25v c3RpY3MsIG FuZCBjbGlu aWNhbCBsYW JvcmF0b3Jp ZXMuPGJyPj IuIERpdmVy c2UgUHJvZH VjdCBQb3J0 Zm9saW86IF RoZSBjb21w YW55IG9mZm VycyBhIGRp dmVyc2Ugcm FuZ2Ugb2Yg aGlnaC1xdW FsaXR5IHBy b2R1Y3RzIG luY2x1ZGlu ZyBhbnRpYm 9kaWVzLCBw cm90ZWlucy wgYXNzYXlz LCBmbG93IG N5dG9tZXRy eSwgaW1hZ2 luZywgYW5k IG1vbGVjdW xhciBiaW9s b2d5IHJlYW dlbnRzLiBU aGlzIGV4dG Vuc2l2ZSBw cm9kdWN0IH BvcnRmb2xp byBhbGxvd3 MgcmVzZWFy Y2hlcnMgYW 5kIGNsaW5p Y2lhbnMgdG 8gYWNjZXNz IGFsbCB0aG UgbmVjZXNz YXJ5IHRvb2 xzIGZvciB0 aGVpciB3b3 JrLjxicj4z LiBDdXR0aW 5nLWVkZ2Ug VGVjaG5vbG 9neTogQmlv LVRlY2huZS B1dGlsaXpl cyBjdXR0aW 5nLWVkZ2Ug dGVjaG5vbG 9neSB0byBk ZXZlbG9wIG FuZCBtYW51 ZmFjdHVyZS BpdHMgcHJv ZHVjdHMuIF RoaXMgaW5j bHVkZXMgYW R2YW5jZWQg cHJvdGVpbi BhbmQgYW50 aWJvZHkgZW 5naW5lZXJp bmcgcGxhdG Zvcm1zLCBm bG93IGN5dG 9tZXRyeSBh bmQgaW1hZ2 luZyBzeXN0 ZW1zLCBhbm QgbW9sZWN1 bGFyIGFuZC BjZWxsIGJp b2xvZ3kgdG VjaG5pcXVl cy48YnI+NC 4gRXhwZXJ0 aXNlIGluIE 11bHRpcGxl IERpc2NpcG xpbmVzOiBC aW8tVGVjaG 5lIGhhcyBl eHBlcnRpc2 UgaW4gbXVs dGlwbGUgZG lzY2lwbGlu ZXMgc3VjaC BhcyBpbW11 bm9sb2d5LC BjZWxsIGJp b2xvZ3ksIG 5ldXJvc2Np ZW5jZSwgYW 5kIG1vbGVj dWxhciBkaW Fnbm9zdGlj cy4gVGhpcy BhbGxvd3Mg dGhlIGNvbX BhbnkgdG8g cHJvdmlkZS Bjb21wcmVo ZW5zaXZlIH NvbHV0aW9u cyBmb3IgYS B3aWRlIHJh bmdlIG9mIH Jlc2VhcmNo IGFyZWFzLj xicj41LiBH bG9iYWwgUm VhY2g6IFdp dGggaGVhZH F1YXJ0ZXJz IGluIHRoZS BVbml0ZWQg U3RhdGVzLC BCaW8tVGVj aG5lIGhhcy BhIGdsb2Jh bCBwcmVzZW 5jZSB3aXRo IG1hbnVmYW N0dXJpbmcg ZmFjaWxpdG llcywgZGlz dHJpYnV0aW 9uIGNlbnRl cnMsIGFuZC BzYWxlcyBv ZmZpY2VzIG luIG11bHRp cGxlIGNvdW 50cmllcy4g VGhpcyBlbm FibGVzIHRo ZSBjb21wYW 55IHRvIHNl cnZlIGN1c3 RvbWVycyBh bGwgb3Zlci B0aGUgd29y bGQuPGJyPj YuIFN0cm9u ZyBTY2llbn RpZmljIENv bGxhYm9yYX Rpb25zOiBU aGUgY29tcG FueSBoYXMg c3Ryb25nIG NvbGxhYm9y YXRpb25zIH dpdGggbGVh ZGluZyBhY2 FkZW1pYyBh bmQgcmVzZW FyY2ggaW5z dGl0dXRpb2 5zLCB3aGlj aCBhbGxvd3 MgdGhlbSB0 byBzdGF5IG F0IHRoZSBm b3JlZnJvbn Qgb2Ygc2Np ZW50aWZpYy BhZHZhbmNl bWVudHMgYW 5kIGRldmVs b3AgbmV3IH Byb2R1Y3Rz Ljxicj43Li BDb21taXRt ZW50IHRvIF F1YWxpdHkg YW5kIFNhZm V0eTogQmlv LVRlY2huZS BoYXMgYSBz dHJpY3QgcX VhbGl0eSBj b250cm9sIH N5c3RlbSBp biBwbGFjZS B0byBlbnN1 cmUgdGhlIH NhZmV0eSBh bmQgZWZmZW N0aXZlbmVz cyBvZiBpdH MgcHJvZHVj dHMuIFRoZX kgaGF2ZSBv YnRhaW5lZC BJU08gMTM0 ODUgY2VydG lmaWNhdGlv biBhbmQgYX JlIGNvbXBs aWFudCB3aX RoIEZEQSBy ZWd1bGF0aW 9ucy48YnI+ OC4gRm9jdX Mgb24gQ3Vz dG9tZXIgU2 VydmljZTog VGhlIGNvbX BhbnkgaGFz IGEgY3VzdG 9tZXItY2Vu dHJpYyBhcH Byb2FjaCBh bmQgaXMgY2 9tbWl0dGVk IHRvIHByb3 ZpZGluZyBl eGNlcHRpb2 5hbCBjdXN0 b21lciBzZX J2aWNlLiBU aGV5IG9mZm VyIHRlY2hu aWNhbCBzdX Bwb3J0LCB0 cmFpbmluZy wgYW5kIGN1 c3RvbWl6ZW Qgc29sdXRp b25zIHRvIG 1lZXQgdGhl IHVuaXF1ZS BuZWVkcyBv ZiB0aGVpci BjdXN0b21l cnMu
What the company's business model?
Bio-Techne

πŸ“ˆ Want to read more about Bio-Techne?

Sign up for free or log in

πŸ“₯ Get our free eBook now: "The Checklist Value Investor β€” A Smarter Way to Pick Stocks"

VGhlIEJpby 1UZWNobmUg Y29tcGFueS dzIGJ1c2lu ZXNzIG1vZG VsIGlzIGZv Y3VzZWQgb2 4gZGV2ZWxv cGluZywgbW FudWZhY3R1 cmluZywgYW 5kIGRpc3Ry aWJ1dGluZy BoaWdoLXF1 YWxpdHkgbG lmZSBzY2ll bmNlIHJlYW dlbnRzIGFu ZCBpbnN0cn VtZW50cyB1 c2VkIGluIG Jpb21lZGlj YWwgcmVzZW FyY2ggYW5k IGNsaW5pY2 FsIGRpYWdu b3N0aWNzLi BUaGlzIGlu Y2x1ZGVzIH Byb2R1Y3Rz IHN1Y2ggYX MgYW50aWJv ZGllcywgcH JvdGVpbnMs IGFzc2F5IG tpdHMsIGFu ZCBpbnN0cn VtZW50cyBm b3IgY2VsbC BhbmQgZ2Vu ZSB0aGVyYX B5LCBpbW11 bm90aGVyYX B5LCBhbmQg bW9sZWN1bG FyIGRpYWdu b3N0aWNzLi BCaW8tVGVj aG5lIHNlbG xzIGl0cyBw cm9kdWN0cy BkaXJlY3Rs eSB0byBjdX N0b21lcnMs IGFzIHdlbG wgYXMgdGhy b3VnaCBkaX N0cmlidXRv cnMgYW5kIE 9FTSAob3Jp Z2luYWwgZX F1aXBtZW50 IG1hbnVmYW N0dXJlcikg cGFydG5lcn NoaXBzLiBU aGUgY29tcG FueSBhbHNv IHByb3ZpZG VzIGNvbnRy YWN0IHJlc2 VhcmNoIGFu ZCBtYW51Zm FjdHVyaW5n IHNlcnZpY2 VzIGZvciB0 aGUgZGV2ZW xvcG1lbnQg YW5kIHByb2 R1Y3Rpb24g b2YgY3VzdG 9tIHJlYWdl bnRzIGFuZC Bhc3NheXMu IEFkZGl0aW 9uYWxseSwg QmlvLVRlY2 huZSBoYXMg c3RyYXRlZ2 ljIGFsbGlh bmNlcyBhbm QgY29sbGFi b3JhdGlvbn Mgd2l0aCBv dGhlciBjb2 1wYW5pZXMg YW5kIG9yZ2 FuaXphdGlv bnMgdG8gYW R2YW5jZSBy ZXNlYXJjaC BhbmQgaW5u b3ZhdGlvbi BpbiB0aGUg bGlmZSBzY2 llbmNlcyBm aWVsZC4=
Is AI a threat?
AI can pose several potential threats to a biotech company like Bio-Techne, particularly in the areas of substitution, disintermediation, and margin pressure.
1. Substitution: AI and advanced computational techniques can lead to the development of new methods for data analysis and interpretation in life sciences, which may substitute some of the traditional products and services that Bio-Techne offers. For instance, AI-driven platforms for drug discovery and personalized medicine can reduce the reliance on existing tools and reagents produced by Bio-Techne, affecting demand.
2. Disintermediation: AI can enable researchers and clinicians to access information and perform analyses directly without the need for intermediaries. With AI tools that allow for idepth genomic analysis or protein characterization, customers may opt to conduct their experiments ihouse, reducing their dependency on Bio-Techne’s products or services.
3. Margin Pressure: The integration of AI into biotech can lead to increased competition and a drive for cost efficiency. Companies utilizing AI technologies may be able to offer similar products at lower prices, pressuring traditional firms like Bio-Techne to lower their margins. As AI tools become more widespread and accessible, Bio-Techne may need to innovate or invest heavily in AI capabilities to remain competitive, which can impact profit margins.
In conclusion, while AI does pose potential threats in these areas, it also offers opportunities for innovation and enhancement of existing products and services. How Bio-Techne navigates these challenges will play a critical role in its ongoing competitive positioning.
Sensitivity to interest rates
The sensitivity of Bio-Techne’s earnings, cash flow, and valuation to changes in interest rates can be understood through several key factors:
1. Cost of Capital: As interest rates increase, the cost of borrowing also rises. This can impact Bio-Techne’s ability to finance new projects, acquisitions, or research and development through debt, potentially leading to higher costs and reduced profitability.
2. Discount Rate: Higher interest rates often lead to a higher discount rate applied to future cash flows in valuation models. For a company like Bio-Techne, which may expect growth in earnings and cash flows over time, a higher discount rate can significantly reduce the present value of these cash flows, leading to lower valuations.
3. Market Sentiment: Rising interest rates can affect investor sentiment and risk appetite. As rates go up, equities may be seen as less attractive compared to fixed-income investments, which could result in selling pressure on Bio-Techne’s stock, thus impacting its market valuation.
4. Impact on Revenue Growth: If interest rates lead to broader economic slowdowns, spending on biotechnology and life sciences products and services may tighten for customers, impacting Bio-Techne’s revenue growth.
5. Operational Costs: Higher interest rates can also lead to increased operational costs if the company has existing variable-rate debt. This could further squeeze margins and cash flow.
In summary, while Bio-Techne’s specific sensitivity to interest rate changes would depend on its financial structure, current debt levels, and operational strategy, the general implications of rising rates could lead to diminished earnings, strained cash flows, and a lower overall valuation.
Resilience to the future changes
Bio-Techne

πŸ“ˆ Want to read more about Bio-Techne?

Sign up for free or log in

πŸ‘₯ Free eBook for new users: "The Checklist Value Investor β€” A Smarter Way to Pick Stocks"

QSByZWFsaX N0aWMgc2Nl bmFyaW8gdG hhdCBjb3Vs ZCBwZXJtYW 5lbnRseSBp bXBhaXIgQm lvLVRlY2hu ZeKAmXMgZW Nvbm9taWNz IG92ZXIgdG hlIG5leHQg M+KAkzUgeW VhcnMgaXMg YSBzdWJzdG FudGlhbCBh bmQgcHJvbG 9uZ2VkIHJl ZHVjdGlvbi BpbiBmdW5k aW5nIGZvci BiaW9tZWRp Y2FsIHJlc2 VhcmNoIGFu ZCBkZXZlbG 9wbWVudC4g VGhpcyBjb3 VsZCBzdGVt IGZyb20gYS Bjb21iaW5h dGlvbiBvZi BmYWN0b3Jz LCBpbmNsdW Rpbmcgc2ln bmlmaWNhbn QgZ2xvYmFs IGVjb25vbW ljIGRvd250 dXJucywgc2 hpZnRzIGlu IGdvdmVybm 1lbnQgcHJp b3JpdGllcy B0aGF0IGxl YWQgdG8gYn VkZ2V0IGN1 dHMgaW4gcm VzZWFyY2gg Z3JhbnRzLC BvciBhZHZl cnNlIHJlZ3 VsYXRvcnkg Y2hhbmdlcy B0aGF0IHJl c3RyaWN0IG Z1bmRpbmcg Zm9yIGJpb3 RlY2ggaW5u b3ZhdGlvbn MuPGJyPklu IHN1Y2ggYS BzY2VuYXJp bywgQmlvLV RlY2huZSB3 b3VsZCBsaW tlbHkgZXhw ZXJpZW5jZS BzZXZlcmFs IHJlcGVyY3 Vzc2lvbnM6 PGJyPjEuID xzdHJvbmc+ TWFyZ2lucz wvc3Ryb25n PjogVGhlIG NvbXBhbnni gJlzIHByb2 ZpdCBtYXJn aW5zIGNvdW xkIHNocmlu ayBzaWduaW ZpY2FudGx5 LiBBIGRvd2 50dXJuIGlu IHJlc2Vhcm NoIGZ1bmRp bmcgd291bG QgbWVhbiBy ZWR1Y2VkIG RlbWFuZCBm b3IgQmlvLV RlY2huZeKA mXMgcHJvZH VjdHMgYW5k IHNlcnZpY2 VzLCB3aGlj aCBhcmUgb2 Z0ZW4gdGll ZCB0byB0aG UgYnVkZ2V0 cyBvZiByZX NlYXJjaCBp bnN0aXR1dG lvbnMgYW5k IGJpb3RlY2 ggY29tcGFu aWVzLiBMb3 dlciBkZW1h bmQgY291bG QgbGVhZCB0 byBwcmljZS ByZWR1Y3Rp b25zIG9yIG xvd2VyIHZv bHVtZSBzYW xlcywgYWR2 ZXJzZWx5IG FmZmVjdGlu ZyBncm9zcy BtYXJnaW5z LiBGdXJ0aG VybW9yZSwg aWYgdGhlIG NvbXBhbnkg bWFpbnRhaW 5zIGl0cyBw cmljaW5nIH N0cnVjdHVy ZSB3aGlsZS B2b2x1bWUg ZGVjcmVhc2 VzLCBpdCB3 b3VsZCBleH BlcmllbmNl IGEgZGlzcH JvcG9ydGlv bmF0ZSBpbX BhY3Qgb24g cHJvZml0YW JpbGl0eS48 YnI+Mi4gPH N0cm9uZz5D YXNoIEZsb3 c8L3N0cm9u Zz46IENhc2 ggZmxvdyBj b3VsZCBkZX RlcmlvcmF0 ZSBhcyByZX ZlbnVlcyBk ZWNsaW5lIG R1ZSB0byBy ZWR1Y2VkIH NhbGVzLiBU aGlzIHJlZH VjZWQgaW5j b21pbmcgY2 FzaCBjb3Vs ZCBsZWFkIH RvIHRpZ2h0 ZXIgbGlxdW lkaXR5LCBt YWtpbmcgaX QgY2hhbGxl bmdpbmcgZm 9yIEJpby1U ZWNobmUgdG 8gbWFuYWdl IG9wZXJhdG luZyBleHBl bnNlcyBhbm QgaW52ZXN0 bWVudHMuIE lmIHRoZSBj b21wYW55IG hhcyBmaXhl ZCBjb3N0cy ByZWxhdGVk IHRvIG1hbn VmYWN0dXJp bmcgYW5kIF ImYW1wO0Qs IHRoZXNlIH dvdWxkIHN0 aWxsIG5lZW QgdG8gYmUg bWV0LCBwb3 RlbnRpYWxs eSByZXN1bH RpbmcgaW4g Y2FzaCBmbG 93IGRlZmlj aXRzLiBBbi BpbmNyZWFz ZSBpbiBhY2 NvdW50cyBy ZWNlaXZhYm xlIGNvdWxk IGFsc28gb2 NjdXIgaWYg Y3VzdG9tZX JzIGRlbGF5 IHBheW1lbn RzIGR1ZSB0 byB0aGVpci Bvd24gZmlu YW5jaWFsIG RpZmZpY3Vs dGllcy48Yn I+My4gPHN0 cm9uZz5CYW xhbmNlIFNo ZWV0PC9zdH Jvbmc+OiBU aGUgYmFsYW 5jZSBzaGVl dCB3b3VsZC BsaWtlbHkg c2hvdyBkZX RlcmlvcmF0 aW9uIG92ZX IgdGltZS4g QSBzbG93ZG 93biBpbiBj YXNoIGluZm xvdyBjb3Vs ZCBsZWFkIH RvIGRpbWlu aXNoZWQgY2 FzaCByZXNl cnZlcywgbm VnYXRpdmVs eSBpbXBhY3 RpbmcgdGhl IGNvbXBhbn nigJlzIGxp cXVpZGl0eS ByYXRpb3Mu IElmIHRoZS Bjb21wYW55 IG9wdHMgdG 8gYm9ycm93 IHRvIHN0YX kgYWZsb2F0 IGR1cmluZy B0b3VnaCBl Y29ub21pYy BwZXJpb2Rz LCBpdHMgZG VidCBsZXZl bHMgY291bG QgaW5jcmVh c2UsIHB1dH RpbmcgcHJl c3N1cmUgb2 4gaXRzIGxl dmVyYWdlIH JhdGlvcy4g QWRkaXRpb2 5hbGx5LCBp ZiBhc3NldH MgYmVjb21l IGltcGFpcm VkIGR1ZSB0 byBkZWNyZW FzZWQgcmV2 ZW51ZSBwcm 9qZWN0aW9u cyBvciBpZi B0aGUgY29t cGFueSBoYX MgdG8gd3Jp dGUgZG93bi BpbnZlbnRv cnksIHRoaX MgY291bGQg ZnVydGhlci B3ZWFrZW4g aXRzIGJhbG FuY2Ugc2hl ZXQuPGJyPk luIHN1bW1h cnksIGlmIG Z1bmRpbmcg Zm9yIGJpb2 1lZGljYWwg cmVzZWFyY2 ggZGVjbGlu ZXMgc2lnbm lmaWNhbnRs eSwgQmlvLV RlY2huZSB3 b3VsZCBzZW UgcmVkdWNl ZCBtYXJnaW 5zIGZyb20g bG93ZXIgc2 FsZXMsIHdl YWtlbmVkIG Nhc2ggZmxv d3MgZHVlIH RvIGRlY3Jl YXNlZCByZX ZlbnVlIGFu ZCBwb3NzaW JseSBpbmNy ZWFzZWQgZG VidCwgYW5k IGEgZGV0ZX Jpb3JhdGlu ZyBiYWxhbm NlIHNoZWV0 IGNoYXJhY3 Rlcml6ZWQg YnkgbG93ZX IgbGlxdWlk aXR5IGFuZC BpbmNyZWFz ZWQgbGlhYm lsaXRpZXMu IFRoaXMgc2 NlbmFyaW8g Y291bGQgaG F2ZSBsYXN0 aW5nIGltcG xpY2F0aW9u cyBmb3IgdG hlIGNvbXBh bnnigJlzIG dyb3d0aCBw cm9zcGVjdH MgYW5kIG9w ZXJhdGlvbm FsIHN0YWJp bGl0eS48Yn I+
Interesting facts about the company
Bio-Techne

πŸ“ˆ Want to read more about Bio-Techne?

Sign up for free or log in

πŸš€ Don’t miss "The Checklist Value Investor β€” A Smarter Way to Pick Stocks" β€” free!

CiAgICAgIC AgICAgIDxk aXYgc3R5bG U9J3dpZHRo OiAxMDAlOy BkaXNwbGF5 OiBmbGV4Oy BqdXN0aWZ5 LWNvbnRlbn Q6IGNlbnRl cjsnPgogIC AgICAgICAg ICAgICAgPG RpdiBzdHls ZT0nCiAgIC AgICAgICAg ICAgICAgIC AgZGlzcGxh eTogZmxleD sKICAgICAg ICAgICAgIC AgICAgICBh bGlnbi1pdG VtczogY2Vu dGVyOwogIC AgICAgICAg ICAgICAgIC AgIGJhY2tn cm91bmQtY2 9sb3I6ICNm MGY0Zjg7Ci AgICAgICAg ICAgICAgIC AgICAgYm9y ZGVyOiAxcH ggc29saWQg I2QxZTNmMD sKICAgICAg ICAgICAgIC AgICAgICBi b3JkZXItcm FkaXVzOiAx MHB4OwogIC AgICAgICAg ICAgICAgIC AgIHBhZGRp bmc6IDEwcH g7CiAgICAg ICAgICAgIC AgICAgICAg bWFyZ2luOi AyMHB4IDA7 CiAgICAgIC AgICAgICAg ICAgICAgZm 9udC1mYW1p bHk6ICJTZW dvZSBVSSIs IFJvYm90by wgc2Fucy1z ZXJpZjsKIC AgICAgICAg ICAgICAgIC AgICBib3gt c2hhZG93Oi AwIDJweCA2 cHggcmdiYS gwLCAwLCAw LCAwLjA1KT sKICAgICAg ICAgICAgIC AgICAgICBt YXgtd2lkdG g6IDkwMHB4 OwogICAgIC AgICAgICAg ICAgICAgIH dpZHRoOiAx MDAlOyc+Cg ogICAgICAg ICAgICAgIC AgICAgIDxp bWcgc3JjPS Jhc3NldHMv bG9nb3MvUn BJYjlQcHBR b2wzQ1VVN3 FMMkIud2Vi cCIgYWx0PS JCaW8tVGVj aG5lIiB0aX RsZT0iQmlv LVRlY2huZS IgIGNsYXNz PSJpbWctZm x1aWQiIGhl aWdodD01MC B3aWR0aD01 MCBsb2FkaW 5nPSdsYXp5 JyBzdHlsZT 0nYm9yZGVy LXJhZGl1cz ogNnB4Oyc+ CgogICAgIC AgICAgICAg ICAgICAgID xkaXYgc3R5 bGU9J2ZsZX g6IDE7IHRl eHQtYWxpZ2 46IGNlbnRl cjsgbWFyZ2 luLWxlZnQ6 IDVweDsnPg ogICAgICAg ICAgICAgIC AgICAgICAg ICA8cCBzdH lsZT0nZm9u dC1zaXplOi AyNnB4OyBj b2xvcjogIz MzMzsgbWFy Z2luLWJvdH RvbTogMTVw eDsnPgogIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAg8J+TiC BXYW50IHRv IHJlYWQgbW 9yZSBhYm91 dCBCaW8tVG VjaG5lPwog ICAgICAgIC AgICAgICAg ICAgICAgIC A8L3A+Cgog ICAgICAgIC AgICAgICAg ICAgICAgIC A8YSBocmVm PSdpbmRleC 5waHA/cGFn ZT1zaWdudX AnIHN0eWxl PScKICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg IGJhY2tncm 91bmQtY29s b3I6ICMwMD dCRkY7CiAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgICBjb2xv cjogI2ZmZj sKICAgICAg ICAgICAgIC AgICAgICAg ICAgICAgIH BhZGRpbmc6 IDEwcHggMj BweDsKICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgIGJvcmRl ci1yYWRpdX M6IDVweDsK ICAgICAgIC AgICAgICAg ICAgICAgIC AgICAgIHRl eHQtZGVjb3 JhdGlvbjog bm9uZTsKIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAgIGZvbn Qtd2VpZ2h0 OiBib2xkOw ogICAgICAg ICAgICAgIC AgICAgICAg ICAgICAgbW FyZ2luLXJp Z2h0OiAxMH B4OwogICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgdHJhbnNp dGlvbjogYm Fja2dyb3Vu ZC1jb2xvci AwLjNzIGVh c2U7JwogIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAgb25tb3 VzZW92ZXI9 J3RoaXMuc3 R5bGUuYmFj a2dyb3VuZE NvbG9yPSIj MDA1NmIzIi cKICAgICAg ICAgICAgIC AgICAgICAg ICAgICAgIG 9ubW91c2Vv dXQ9J3RoaX Muc3R5bGUu YmFja2dyb3 VuZENvbG9y PSIjMDA3Qk ZGIic+CiAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgICBTaWdu IHVwIGZvci BmcmVlCiAg ICAgICAgIC AgICAgICAg ICAgICAgID wvYT4KCiAg ICAgICAgIC AgICAgICAg ICAgICAgID xzcGFuIHN0 eWxlPSdtYX JnaW46IDAg OHB4OyBjb2 xvcjogIzU1 NTsnPm9yPC 9zcGFuPgoK ICAgICAgIC AgICAgICAg ICAgICAgIC AgPGEgaHJl Zj0naW5kZX gucGhwP3Bh Z2U9bG9naW 4nIHN0eWxl PScKICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg IGNvbG9yOi AjMDA3QkZG OwogICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg dGV4dC1kZW NvcmF0aW9u OiB1bmRlcm xpbmU7CiAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgICBmb250 LXdlaWdodD ogNTAwOyc+ CiAgICAgIC AgICAgICAg ICAgICAgIC AgICAgICBs b2cgaW4KIC AgICAgICAg ICAgICAgIC AgICAgICAg PC9hPgoKCi AgICAgICAg ICAgICAgIC AgICAgICAg IDxwIHN0eW xlPSdtYXJn aW4tdG9wOi AxNXB4OyBm b250LXNpem U6IDEzcHg7 IGZvbnQtd2 VpZ2h0OiBi b2xkOyBjb2 xvcjogI2Qz MmYyZjsnPg ogICAgICAg ICAgICAgIC AgICAgICAg ICAgICAg8J +TnSBKb2lu IHVzIGFuZC BncmFiIHlv dXIgY29weS BvZiA8aT4i VGhlIENoZW NrbGlzdCBW YWx1ZSBJbn Zlc3RvciDi gJQgQSBTbW FydGVyIFdh eSB0byBQaW NrIFN0b2Nr cyI8L2k+Ci AgICAgICAg ICAgICAgIC AgICAgICAg IDwvcD4KCi AgICAgICAg ICAgICAgIC AgICAgICAg IDwhLS0KIC AgICAgICAg ICAgICAgIC AgICAgICAg PGRpdiBzdH lsZT0nbWFy Z2luLXRvcD ogMTJweDsg Zm9udC1zaX plOiAxM3B4 OyBjb2xvcj ogIzQ0NDsn PgogICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg U2lnbiB1cC Bub3cgYW5k IGdldCBvdX IgZnJlZSBl Qm9vayAKIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAgIDxiPl RoZSBDaGVj a2xpc3QgVm FsdWUgSW52 ZXN0b3Ig4o CUIEEgU21h cnRlciBXYX kgdG8gUGlj ayBTdG9ja3 M8L2I+CiAg ICAgICAgIC AgICAgICAg ICAgICAgID wvZGl2Pgog ICAgICAgIC AgICAgICAg ICAgICAgIC AtLT4KICAg ICAgICAgIC AgICAgICAg ICAgICAgPC EtLQogICAg ICAgICAgIC AgICAgICAg ICAgICA8ZG l2IHN0eWxl PSdtYXJnaW 4tdG9wOiAx NnB4OyBmb2 50LXNpemU6 IDE0cHg7IG NvbG9yOiAj NDQ0OyBmb2 50LWZhbWls eTogLWFwcG xlLXN5c3Rl bSwgQmxpbm tNYWNTeXN0 ZW1Gb250LC BTZWdvZSBV SSwgUm9ib3 RvLCBIZWx2 ZXRpY2EgTm V1ZSwgc2Fu cy1zZXJpZj sgbGluZS1o ZWlnaHQ6ID EuNjsnPgog ICAgICAgIC AgICAgICAg ICAgICAgIC AgICAgSGF2 ZSB5b3UgaG VhcmQgYWJv dXQgb3VyIH Nob3J0IDxz dHJvbmcgc3 R5bGU9J2Zv bnQtd2VpZ2 h0OiA2MDA7 Jz5EYWlseS BWaWRlbyBO ZXdzbGV0dG VyPC9zdHJv bmc+PwogIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAgPGEgaH JlZj0naHR0 cHM6Ly93d3 cuaW5zaWdo dGZ1bHZhbH VlLmNvbS9u ZXdzbGV0dG VyLnBocCcg dGFyZ2V0PS dfYmxhbmsn IHN0eWxlPS djb2xvcjog IzAwN0JGRj sgdGV4dC1k ZWNvcmF0aW 9uOiBub25l OyBmb250LX dlaWdodDog NTAwOyBtYX JnaW4tbGVm dDogNnB4Oy c+CiAgICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgICAgRmlu ZCBvdXQgbW 9yZQogICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgPC9hPgog ICAgICAgIC AgICAgICAg ICAgICAgIC A8L2Rpdj4K ICAgICAgIC AgICAgICAg ICAgICAgIC AgLS0+CiAg ICAgICAgIC AgICAgICAg ICAgPC9kaX Y+CiAgICAg ICAgICAgIC AgICA8L2Rp dj4KICAgIC AgICAgICAg PC9kaXY+Ci AgICAgICAg ICAgIAogIC AgICAgIAog ICAgICAgID xzcGFuIGNs YXNzPSdibH VycmVkLXRl eHQnPgogIC AgICAgICAg ICBNUzRnUW 1sdkxWIFJs WTJodVpTQk QgYjNKd2Iz SmhkRyBsdm JpQjNZWE1n IFptOTFibV JsWkMgQnBi aUF4T1RjMi BJR0Z1WkNC M1lYIE1nYj NKcFoybHUg WVd4c2VTQn JibSA5M2Jp QmhjeUJVIF pXTm9ibVVn UTIgOXljRz l5WVhScCBi MjR1UEdKeV BqIEl1SUZS b1pTQmogYj Ixd1lXNTVJ SCBOMFlYSj BaV1FnIFlY TWdZU0J0WV cgNTFabUZq ZEhWeSBaWE lnYjJZZ2FX IDV6ZEhKMW JXVnUgZEhN Z2RYTmxaQy BCbWIzSWdh VzF0IGRXNX ZaR2xoWjIg NXZjM1JwWT NNcyBJSE53 WldOcFptIG xqWVd4c2VT Qm0gYjNJZ2 JXVmhjMyBW eWFXNW5JR0 41IGRHOXJh VzVsY3kgQm hibVFnYVc1 MCBaWEptWl hKdmJuIE11 SUR4aWNqNH ogTGlCSmJp QXhPVCBrNU xDQjBhR1Vn IFkyOXRjR0 Z1ZVMgQmhZ M0YxYVhKbC BaQ0JTSmtR Z1UzIGx6ZE dWdGN5d2cg WVNCc1pXRm thVyA1bklI TjFjSEJzIG FXVnlJRzlt SUggQnliM1 JsYVc1eiBM Q0JoYm5ScF ltIDlrYVdW ekxDQmggYm 1RZ2FXMXRk VyA1dllYTn pZWGtnIGNI SnZaSFZqZE ggTXVJRlJv YVhNZyBZV0 54ZFdsemFY IFJwYjI0Z2 JXRnkgYTJW a0lIUm9aUy BCaVpXZHBi bTVwIGJtY2 diMllnUW0g bHZMVlJsWT JodSBaZUtB bVhNZ1pYIG h3WVc1emFX OXUgSUdsdW RHOGdkRyBo bElHeHBabV VnIGMyTnBa VzVqWlggTW diV0Z5YTJW MCBManhpY2 o0MExpIEJD YVc4dFZHVm ogYUc1bElH aGhjeSBCaE lHZHNiMkpo IGJDQndjbV Z6WlcgNWpa U3dnZDJsMC BhQ0J2Y0dW eVlYIFJwYj I1eklHbHUg SUc5MlpYSW dOVCBBZ1ky OTFiblJ5IG FXVnpJR0Z1 WkMgQmpkWE 4wYjIxbCBj bk1nYVc0Z2 IzIFpsY2lB eE16VWcgWT I5MWJuUnlh VyBWekxqeG ljajQxIExp QlVhR1VnWT IgOXRjR0Z1 ZWVLQSBtWE 1nY0hKdlpI IFZqZEhNZ1 lYSmwgSUhW elpXUWdhVy A0Z2RtRnlh VzkxIGN5Qm 1hV1ZzWkgg TWdjM1ZqYU NCaCBjeUJ0 WldScFkyIE ZzSUhKbGMy VmggY21Ob0 xDQmtjbiBW bklHUmxkbV ZzIGIzQnRa VzUwTEMgQm hibVFnWkds aCBaMjV2Yz NScFkzIE11 UEdKeVBqWX UgSUVKcGJ5 MVVaVyBOb2 JtWGlnSmx6 IElHaGxZV1 J4ZFcgRnlk R1Z5Y3lCaC BjbVVnYkc5 allYIFJsWk NCcGJpQk4g YVc1dVpXRn diMiB4cGN5 d2dUV2x1IG JtVnpiM1Jo TEMgQmhibV FnYVhRZyBh R0Z6SUcxaG JuIFZtWVdO MGRYSnAgYm 1jZ1ptRmph VyB4cGRHbG xjeUJwIGJp QjBhR1VnVl cgNXBkR1Zr SUZOMCBZWF JsY3l3Z1Ey IEZ1WVdSaE xDQkQgYUds dVlTd2dZVy A1a0lFVjFj bTl3IFpTND hZbkkrTnkg NGdWR2hsSU dOdiBiWEJo Ym5rZ2FHIE Z6SUc5MlpY SWcgTXl3NE 1EQWdaVyAx d2JHOTVaV1 Z6IElIZHZj bXhrZDIgbG taUzQ4WW5J KyBPQzRnU1 c0Z01qIEF5 TUN3Z1FtbH YgTFZSbFky aHVaUyBCM1 lYTWdibUZ0 IFpXUWdiMj VsSUcgOW1J SFJvWlNCWC BiM0pzWk9L QW1YIE1nVF c5emRDQkog Ym01dmRtRj BhWCBabElF TnZiWEJoIG JtbGxjeUJp ZVMgQkdiM0 ppWlhNZyBi V0ZuWVhwcG JtIFV1UEdK eVBqa3UgSU ZSb1pTQmpi MiAxd1lXNT VJR2x6IElH eHBjM1JsWk MgQnZiaUIw YUdVZyBUa0 ZUUkVGUklI IE4wYjJOck lHVjQgWTJo aGJtZGxJSC BWdVpHVnlJ SFJvIFpTQj BhV05yWlgg SWdjM2x0WW 05cyBJRlJG UTBndVBHIE p5UGpFd0xp QkMgYVc4dF ZHVmphRyA1 bElHbHpJR0 52IGJXMXBk SFJsWkMgQj BieUJ6ZFhO MCBZV2x1WV dKcGJHIGww ZVNCaGJtUW cgYUdGeklI SmxaSCBWal pXUWdhWFJ6 IElHTmhjbU p2YmkgQmxi V2x6YzJsdi Bibk1nWW5r Z056IEFsSU hOcGJtTmwg SURJd01UVX VJRSBsMElH RnNjMjhnIG FHRnpJR0Vn Y0ggSnZaM0 poYlNCcCBi aUJ3YkdGal pTIEIwYnlC eVpXUjEgWT JVZ2MybHVa MiB4bExYVn paU0J3IGJH RnpkR2xqSU cgbHVJR2ww Y3lCdyBjbT lrZFdOMGN5 IEJoYm1RZ2 NHRmogYTJG bmFXNW5Mai B4aWNqNHhN UzRnIFNXNG dZV1JrYVgg UnBiMjRnZE c4ZyBhWFJ6 SUcxaGFXID RnWVhKbFlY TWcgYjJZZ1 ptOWpkWCBN c0lFSnBieT FVIFpXTm9i bVVnWVcgeH pieUJ2Wm1a bCBjbk1nWT NWemRHIDl0 SUcxaGJuVm 0gWVdOMGRY SnBibSBjZ2 MyVnlkbWxq IFpYTWdabT l5SUcgTjFj M1J2YldWeS BjeUJwYmlC MGFHIFVnWW 1sdmRHVmog YUNCcGJtUj FjMyBSeWVT NDhZbkkrIE 1USXVJRlJv WlMgQmpiMj F3WVc1NSBJ R2hoY3lCeV pXIE5sYVha bFpDQnQgZF d4MGFYQnNa UyBCaGQyRn laSE1nIFlX NWtJSEpsWT IgOW5ibWww YVc5dSBJR1 p2Y2lCcGRI IE1nY0hKdl pIVmogZEhN Z1lXNWtJSC BObGNuWnBZ MlZ6IExDQn BibU5zZFcg UnBibWNnZE dobCBJRU5w ZEdWQllpIE JoZDJGeVpD Qm0gYjNJZ1 FtVnpkQyBC QmJuUnBZbT lrIGVTQlRk WEJ3YkcgbG xjaUJoYm1R ZyBkR2hsSU ZOamFXIFZ1 ZEdsemRIUG kgZ0prZ1Ey aHZhVyBObE lFRjNZWEpr IElHWnZjaU JDWlggTjBJ RTVsZHlCTS BhV1psSUZO amFXIFZ1WT JWeklGQnkg YjJSMVkzUX VQRyBKeVBq RXpMaUJDIG FXOHRWR1Zq YUcgNWxJR2 x6SUdsdSBk bTlzZG1Wa0 lHIGx1SUha aGNtbHYgZF hNZ2NHaHBi RyBGdWRHaH liM0JwIFl5 QmxabVp2Y2 4gUnpMQ0Jw Ym1OcyBkV1 JwYm1jZ1pH IDl1WVhScG JtY2cgWm5W dVpITWdZVy A1a0lIQnli MlIxIFkzUn pJSFJ2SUgg TjFjSEJ2Y2 5RZyBiV1Zr YVdOaGJDIE J5WlhObFlY SmogYUNCaG JtUWdjSCBK dmRtbGthVz VuIElHWnBi bUZ1WTIgbG hiQ0J6ZFhC dyBiM0owSU dadmNpIEJ2 Y21kaGJtbD YgWVhScGIy NXpJSCBkdm NtdHBibWNn IGRHOTNZWE prY3kgQnpi Mk5wWVd3Zy BhblZ6ZEds alpTIEJoYm 1RZ1pYRjEg WVd4cGRIa3 VQRyBKeVBq RTBMaUJKIG JpQXlNREl4 TEMgQkNhVz h0VkdWaiBh RzVsSUdGdW JtIDkxYm1O bFpDQmggSU hCaGNuUnVa WCBKemFHbH dJSGRwIGRH Z2dkR2hsSU UgSnBiR3dn WVc1ayBJRT FsYkdsdVpH IEVnUjJGMF pYTWcgUm05 MWJtUmhkRy BsdmJpQjBi eUJrIFpYWm xiRzl3SUcg RnVaQ0J0WV c1MSBabUZq ZEhWeVpTIE JoSUc1dmRt VnMgSUhCeW IzUmxhVyA0 dFltRnpaV1 FnIFEwOVdT VVF0TVQga2 dkbUZqWTJs dSBaUzQ4WW 5JK01UIFV1 SUZSb1pTQm ogYjIxd1lX NTU0byBDWm N5QnRhWE56 IGFXOXVJR2 x6SUggUnZJ SEJ5YjNacC BaR1VnYVc1 dWIzIFpoZE dsMlpTQjAg YjI5c2N5Qm hibSBRZ2Nt VnpiM1Z5IF kyVnpJSFJ2 SUcgRmtkbU Z1WTJVZyBk R2hsSUhWdV pHIFZ5YzNS aGJtUnAgYm 1jZ2IyWWdZ bSBsdmJHOW 5lU0JoIGJt UWdkRzhnWV cgTmpaV3hs Y21GMCBaU0 IwYUdVZ1pH IGx6WTI5Ml pYSjUgSUdG dVpDQmtaWC BabGJHOXdi V1Z1IGRDQn ZaaUJ1Wlgg Y2dkR2hsY2 1GdyBaWFYw YVdOekxnID 09CiAgICAg ICAgPC9zcG FuPgogICAg ICAgIAogIC AgICAgIA==
See Company Q&A
Bio-Techne

πŸ“Š Get full analytics about Bio-Techne

Sign up for free or log in

πŸ‘₯ Free eBook for new users: "The Checklist Value Investor β€” A Smarter Way to Pick Stocks"

© 2024 - 2026 InsightfulValue.com. All rights reserved. Newsletter
Legal